Since 2014, UMR1227 has been strongly involved in European-scale projects, in particular through the European Union's Horizon 2020 framework programme for research and innovation and the joint public/private IMI initiative, which aims to accelerate the development of innovative medicines and patient access to them.
Taxonomy, Treatment, Targets and Remission. Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
New Clinical Endpoints in Primary Sjogren's Syndrome: An Interventional Trial based on stratifying patients
Single cells iN AuToimmUne inflammatoRy disEases
HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making
Molecular Reclassification to Find Clinically Useful Biomarkers for SADs
Stratified medicine in primary Sjögren’s syndrome